Darter logo


DARTER Training school “The guide to antisense development”, February 3-7, Porto, Portugal

This training school is intended for those who are new in the antisense therapy field. Topics discussed include choosing the right antisense modality, how to properly test antisense therapies, how to select the best model systems, and how to prepare for clinical trials with antisense therapies. For more information on [...]


Joined workshop: Model Systems & Safety and Toxicology

Around 75 members of our COST action on Delivery of Antisense RNA Therapeutics from more than 15 different countries and invited speakers met in Munich on October 11th and 12th to discuss model systems and safety and toxicology for RNA therapeutics. The meeting was organized by Alex Garanto (leader of WG2), Aurélie Goyenvalle (leader WG3) and Sabine [...]


OTS Meeting

Incorporated in 2004 as a 501(c)6 nonprofit and registered with the U.S. government, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics. The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in [...]


Inaugural Meeting Bilbao (25th-28th February 2019)

The Inaugural Meeting of COST ACTION CA17103 "DELIVERY OF ANTISENSE RNA THERAPIES (DARTER)" took place on 25th-28th February 2019 in Spain. The meeting was held at Salón de Actos, Hospital Universitario Cruces, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. There were three main objectives for this meeting: 1) to have a snapshot [...]


DARTER – Winter School on Nucleic Acid Chemistry and Therapy

The venue took place on 13 to 17 of January 2019 in Karolinska Instituet in Stockholm. DARTER organised it with the great help of Prof. Roger Strömberg, the host of the DARTER Winter School. The lectures focused on nucleic acid chemistry (basic reactions of nucleic acids and their components, synthesis of oligonucleotides, common [...]

Go to Top